







































Volume 03 Issue 07-2023 15 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

 

 

 

 

 

 

 

 

ABSTRACT 

Osteoporosis is a silent and often overlooked disease characterized by reduced bone density and increased fracture 

risk. It affects millions of people worldwide, predominantly women in postmenopausal years and older adults. This 

abstract aims to shed light on the significance of osteoporosis, its underlying causes, and strategies for its 

management. The abstract highlights the importance of early detection and diagnosis through bone density testing 

and discusses preventive measures such as adequate calcium and vitamin D intake, weight-bearing exercises, and 

lifestyle modifications. Additionally, it emphasizes the role of pharmacological interventions, including 

bisphosphonates, hormone replacement therapy, and newer medications, in the treatment of osteoporosis. The 

abstract concludes by emphasizing the need for public awareness, healthcare provider education, and policy 

interventions to address the burden of osteoporosis and improve patient outcomes. 

KEYWORDS 

Osteoporosis, bone density, fracture risk, postmenopausal women, older adults, early detection, diagnosis, preventive 

measures, calcium, vitamin D, exercise, lifestyle modifications, pharmacological interventions, bisphosphonates, 

hormone replacement therapy, public awareness. 

INTRODUCTION

  Research Article 

 

UNVEILING OSTEOPOROSIS: UNDERSTANDING A HIDDEN DISEASE AND 

ITS MANAGEMENT 
 

Submission Date: July 07, 2023, Accepted Date:  July 12, 2023,  

Published Date: July 17, 2023  

Crossref doi: https://doi.org/10.37547/ajbspi/Volume03Issue07-04 

 

 

B Arun Reddy 
Department Of Pharmacy Practice, S.J.M.Collegeof Pharmacy, Chitradurga, India 

Journal Website: 

https://theusajournals.

com/index.php/ajbspi 

Copyright: Original 

content from this work 

may be used under the 

terms of the creative 

commons attributes 

4.0 licence. 

 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/
https://doi.org/10.37547/ajbspi/Volume03Issue07-04
https://doi.org/10.37547/ajbspi/Volume03Issue07-04
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi


Volume 03 Issue 07-2023 16 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

Osteoporosis, often referred to as a "hidden disease," 

is a prevalent and underdiagnosed condition 

characterized by reduced bone density and increased 

fracture risk. It affects millions of people worldwide, 

predominantly postmenopausal women and older 

adults. Osteoporosis is often asymptomatic until a 

fracture occurs, making it challenging to detect and 

manage effectively. This introduction aims to shed 

light on the significance of osteoporosis, its underlying 

causes, and strategies for its management. 

Osteoporosis is a major public health concern due to its 

impact on individuals' health, well-being, and quality of 

life. Fractures associated with osteoporosis can lead to 

severe pain, disability, and even mortality, particularly 

in older adults. Moreover, the economic burden of 

osteoporosis-related fractures places a substantial 

strain on healthcare systems and societies. 

Understanding the risk factors and pathophysiology of 

osteoporosis is essential for its effective management. 

Risk factors include age, gender, genetics, hormonal 

changes (such as menopause), low calcium and vitamin 

D intake, sedentary lifestyle, smoking, excessive 

alcohol consumption, certain medical conditions (such 

as rheumatoid arthritis) and medications (such as 

corticosteroids). These factors contribute to the 

gradual loss of bone mass, resulting in weakened and 

fragile bones. 

Management of osteoporosis involves a 

comprehensive approach aimed at reducing fracture 

risk and improving bone health. Strategies for 

management include early detection through bone 

mineral density testing, preventive measures such as 

adequate calcium and vitamin D intake, weight-bearing 

exercises, fall prevention strategies, and lifestyle 

modifications. Pharmacological interventions, such as 

bisphosphonates, hormone replacement therapy, and 

newer medications, are also employed to enhance 

bone density and reduce fracture risk. 

Patient education, public awareness campaigns, and 

healthcare provider training are crucial for identifying 

individuals at risk, promoting early diagnosis, and 

ensuring appropriate management of osteoporosis. 

Policy interventions, including guidelines for screening 

and treatment, reimbursement policies, and 

healthcare system integration, are needed to address 

the burden of osteoporosis on a broader scale. 

By unveiling the hidden nature of osteoporosis and 

understanding its management strategies, individuals, 

healthcare professionals, and policymakers can work 

together to prevent fractures, improve the quality of 

life for those affected by osteoporosis, and reduce the 

burden of this silent disease on individuals and society. 

 

METHOD 

Literature Review:  

A comprehensive review of scientific literature was 

conducted to gather information on the prevalence, 

risk factors, and management strategies for 

osteoporosis. Relevant studies, guidelines, and expert 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 07-2023 17 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

opinions were examined to obtain a comprehensive 

understanding of the disease. 

 

Prevalence and Risk Factors: The prevalence of 

osteoporosis and associated fractures, including 

regional and gender variations, were assessed by 

reviewing population-based studies and 

epidemiological data. Risk factors, such as age, gender, 

genetics, lifestyle factors, and comorbidities, were 

analyzed to understand their influence on the 

development and progression of osteoporosis. 

 

Diagnostic Methods: Various diagnostic methods for 

osteoporosis, including bone mineral density (BMD) 

testing using dual-energy X-ray absorptiometry (DXA), 

were explored. The importance of early detection and 

diagnosis in identifying individuals at risk and initiating 

appropriate management strategies was emphasized. 

 

Preventive Measures: Strategies for preventing 

osteoporosis and reducing fracture risk were 

investigated. This included reviewing 

recommendations for adequate calcium and vitamin D 

intake, weight-bearing exercises, fall prevention, and 

lifestyle modifications such as smoking cessation and 

moderation of alcohol consumption. 

 

Pharmacological Interventions: The role of 

pharmacological interventions in the management of 

osteoporosis was examined. This involved reviewing 

the effectiveness, safety, and side effects of 

medications commonly used in osteoporosis 

treatment, such as bisphosphonates, hormone 

replacement therapy, selective estrogen receptor 

modulators, and newer medications like denosumab 

and teriparatide. 

 

Patient Education and Public Awareness: The 

importance of patient education, healthcare provider 

awareness, and public awareness campaigns in 

increasing knowledge about osteoporosis, promoting 

early detection, and encouraging adherence to 

management strategies was emphasized. 

 

Policy Interventions: The need for policy interventions, 

including guidelines for osteoporosis screening and 

management, reimbursement policies for diagnostic 

tests and medications, and healthcare system 

integration, was discussed to improve osteoporosis 

management on a broader scale. 

 

By employing a comprehensive review of literature, 

this study aimed to provide insights into osteoporosis 

as a hidden disease and strategies for its management. 

The findings contribute to raising awareness, 

improving diagnostic practices, and enhancing the 

overall care and outcomes of individuals affected by 

osteoporosis. 

 

RESULTS 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 07-2023 18 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

Prevalence and Risk Factors: Osteoporosis was found 

to be a prevalent condition, particularly among 

postmenopausal women and older adults. The review 

of literature revealed several risk factors associated 

with osteoporosis, including age, gender, genetics, low 

calcium and vitamin D intake, sedentary lifestyle, 

smoking, excessive alcohol consumption, and certain 

medical conditions and medications. 

 

Diagnostic Methods: The review highlighted the 

importance of early detection and diagnosis of 

osteoporosis through bone mineral density (BMD) 

testing, specifically using dual-energy X-ray 

absorptiometry (DXA). DXA scans help assess bone 

density and identify individuals at risk of fractures. 

 

Preventive Measures: Adequate calcium and vitamin D 

intake, weight-bearing exercises, fall prevention 

strategies, and lifestyle modifications were identified 

as key preventive measures for osteoporosis. These 

interventions aim to maintain bone health, improve 

bone density, and reduce the risk of fractures. 

 

Pharmacological Interventions: Pharmacological 

interventions play a crucial role in the management of 

osteoporosis. Bisphosphonates, hormone 

replacement therapy, selective estrogen receptor 

modulators, and newer medications like denosumab 

and teriparatide were identified as effective 

treatments for improving bone density and reducing 

fracture risk. However, the selection of medication 

should be based on individual patient characteristics, 

preferences, and potential side effects. 

 

DISCUSSION 

The results of this study emphasize the importance of 

understanding osteoporosis as a hidden disease and 

implementing appropriate management strategies. 

Early detection through BMD testing can identify 

individuals at risk, enabling timely interventions to 

prevent fractures and manage the condition 

effectively. Preventive measures such as calcium and 

vitamin D intake, exercise, and lifestyle modifications 

are crucial in maintaining bone health and reducing the 

burden of osteoporosis. 

Pharmacological interventions provide additional 

support in the management of osteoporosis. The 

choice of medication should be individualized, taking 

into consideration factors such as efficacy, safety, 

patient preferences, and potential side effects. Regular 

monitoring and adherence to treatment plans are 

essential to optimize outcomes and reduce the risk of 

fractures. 

Patient education and public awareness campaigns 

play a vital role in improving osteoporosis 

management. By increasing knowledge about 

osteoporosis, its risk factors, and available 

management strategies, individuals can take proactive 

steps to protect their bone health. Healthcare provider 

awareness and training are also crucial in ensuring 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 07-2023 19 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

accurate diagnosis, appropriate treatment selection, 

and patient education. 

 

CONCLUSION 

Osteoporosis, often considered a hidden disease, 

poses significant health risks and impacts the quality of 

life of affected individuals. Early detection, preventive 

measures, and appropriate management strategies are 

essential for reducing fracture risk and improving 

patient outcomes. This study highlights the 

importance of regular BMD testing, preventive 

measures such as calcium and vitamin D intake and 

exercise, and pharmacological interventions when 

necessary. Patient education, public awareness, and 

healthcare provider training are crucial components of 

successful osteoporosis management. By 

implementing comprehensive strategies, healthcare 

systems can effectively address osteoporosis as a 

hidden disease and improve the overall health and 

well-being of individuals affected by this condition. 

 

REFERENCES 

1. Kanis, J. A., Cooper, C., Rizzoli, R., Reginster, J. Y., 

& Scientific Advisory Board of the European 

Society for Clinical and Economic Aspects of 

Osteoporosis (ESCEO) and the Committees of 

Scientific Advisors and National Societies of the 

International Osteoporosis Foundation (IOF). 

(2019). European guidance for the diagnosis and 

management of osteoporosis in postmenopausal 

women. Osteoporosis International, 30(1), 3-44. 

2. Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, 

E. M., Tanner, B., Randall, S., ... & National 

Osteoporosis Foundation. (2014). Clinician's guide 

to prevention and treatment of osteoporosis. 

Osteoporosis International, 25(10), 2359-2381. 

3. Compston, J., Bowring, C., Cooper, A., Cooper, C., 

Davies, C., Francis, R., ... & National Osteoporosis 

Guideline Group. (2017). Diagnosis and 

management of osteoporosis in postmenopausal 

women and older men in the UK: National 

Osteoporosis Guideline Group (NOGG) update 

2013. Maturitas, 105, 80-86. 

4. Kanis, J. A., Harvey, N. C., Cooper, C., Johansson, H., 

Odén, A., McCloskey, E. V., ... & Group, F. E. T. A. 

(2016). A systematic review of intervention 

thresholds based on FRAX: a report prepared for 

the National Osteoporosis Guideline Group and the 

International Osteoporosis Foundation. Archives 

of Osteoporosis, 11(1), 25. 

5. International Osteoporosis Foundation. (2021). 

Osteoporosis: What is osteoporosis and what 

causes it? Retrieved from 

https://www.iofbonehealth.org/what-is-

osteoporosis 

6. National Osteoporosis Foundation. (2021). 

Osteoporosis overview. Retrieved from 

https://www.nof.org/preventing-

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 03 Issue 07-2023 20 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 03 ISSUE 07 PAGES: 15-20 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) 
OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

fractures/general-facts/what-women-need-to-

know/ 

7. Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. 

T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. 

(2019). Osteoporosis in men: an Endocrine Society 

clinical practice guideline. The Journal of Clinical 

Endocrinology & Metabolism, 104(5), 1065-1093. 

 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=

